These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17953881)

  • 1. [Integration of new and future biomarkers in the treatment of breast cancer].
    Würtz SØ; Henriksen KL; Lykkesfeldt A; Celis J; Brünner NA
    Ugeskr Laeger; 2007 Sep; 169(36):2999-3003. PubMed ID: 17953881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biomarkers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biomarkers, tumor markers and prognostic markers in breast cancer].
    Kurebayashi J
    Nihon Rinsho; 2006 Mar; 64(3):461-6. PubMed ID: 16529036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive markers in breast cancer--the future.
    Faratian D; Bartlett J
    Histopathology; 2008 Jan; 52(1):91-8. PubMed ID: 18171420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging biomarkers in breast cancer care.
    Napieralski R; Brünner N; Mengele K; Schmitt M
    Biomark Med; 2010 Aug; 4(4):505-22. PubMed ID: 20701440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new predictive markers for endocrine therapy and resistance in breast cancer.
    Henriksen KL; Sonne-Hansen K; Kirkegaard T; Frogne T; Lykkesfeldt AE
    Acta Oncol; 2008; 47(4):795-801. PubMed ID: 18465351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker studies and other difficult inferential problems: statistical caveats.
    Berry DA
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S17-22. PubMed ID: 17512432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker research in breast cancer.
    Maxwell C
    Clin J Oncol Nurs; 2010 Dec; 14(6):771-83. PubMed ID: 21112854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of prognostic profiling in breast cancer.
    Pusztai L
    Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models.
    Hwa HL; Kuo WH; Chang LY; Wang MY; Tung TH; Chang KJ; Hsieh FJ
    J Eval Clin Pract; 2008 Apr; 14(2):275-80. PubMed ID: 18284517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions.
    Sneige N
    Diagn Cytopathol; 2004 Mar; 30(3):158-65. PubMed ID: 14986295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP-1 as a tumor marker in breast cancer--an update.
    Würtz SO; Schrohl AS; Mouridsen H; Brünner N
    Acta Oncol; 2008; 47(4):580-90. PubMed ID: 18465326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance of predictive markers in breast cancer.
    Rhodes A; Barnes DM
    Methods Mol Med; 2004; 97():29-57. PubMed ID: 15064483
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer.
    Henry NL; Hayes DF
    Oncologist; 2006 Jun; 11(6):541-52. PubMed ID: 16794234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer: the search for new prognostic markers.
    Davis AR
    Br J Biomed Sci; 1996 Jun; 53(2):157-61. PubMed ID: 8757694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients.
    Oakman C; Moretti E; Galardi F; Santarpia L; Di Leo A
    Cancer Treat Rev; 2009 Dec; 35(8):662-7. PubMed ID: 19758759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.